{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:19:05Z","timestamp":1741238345649,"version":"3.38.0"},"reference-count":48,"publisher":"JLE","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.nephro.2008.03.005","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T15:46:25Z","timestamp":1212507985000},"page":"150-156","source":"Crossref","is-referenced-by-count":0,"title":["Syndrome h\u00e9pator\u00e9nal"],"prefix":"10.1684","volume":"5","author":[{"given":"A.","family":"Lautrette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Liotier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Deteix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Souweine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18929","reference":[{"key":"10.1016\/j.nephro.2008.03.005_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/00000441-186304000-00002","article-title":"Clinical report on hydro-peritoneum, based on analysis of forty-six cases","volume":"45","author":"Flint","year":"1863","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.nephro.2008.03.005_bib2","unstructured":"Complications de l\u2019hypertension portale chez l\u2019adulte\u00a0: conf\u00e9rence de consensus. Paris, 4 et 5 d\u00e9cembre 2003. www.afssaps.sante.fr."},{"key":"10.1016\/j.nephro.2008.03.005_bib3","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1164\/rccm.200303-361UP","article-title":"Advances in Critical Care Hepatology","volume":"168","author":"Marrero","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra035021","article-title":"Management of cirrhosis and ascites","volume":"350","author":"Gin\u00e8s","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.510230122","article-title":"Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club","volume":"23","author":"Arroyo","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib6","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM196906192802501","article-title":"Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functional nature of renal failure in advanced liver disease","volume":"280","author":"Koppel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gines","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2008.03.005_bib8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/gut.40.5.664","article-title":"Reduction in renal blood flow following acute increase in the portal pressure: evidence for the existence of a hepatorenal reflex in man?","volume":"40","author":"Jalan","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2008.03.005_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM199808203390807","article-title":"Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis","volume":"339","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib11","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1148\/radiology.164.2.2955448","article-title":"Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease","volume":"164","author":"Sato","year":"1987","journal-title":"Radiology"},{"key":"10.1016\/j.nephro.2008.03.005_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(00)80422-5","article-title":"Complications of cirrhosis. I. Portal hypertension","volume":"32","author":"Bosch","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib14","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gin\u00e8s","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2008.03.005_bib15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0168-8278(03)00160-0","article-title":"Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease","volume":"39","author":"Brinch","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib17","first-page":"S47","article-title":"Hepatorenal syndrome: definition, pathophysiology, clinical features and management","volume":"66","author":"Bataller","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.03.005_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1055\/s-2007-1007201","article-title":"Hepatorenal syndrome","volume":"17","author":"Bataller","year":"1997","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nephro.2008.03.005_bib19","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2008.03.005_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s001340050780","article-title":"Renal failure in liver disease","volume":"25","author":"Eckardt","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib21","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3748\/wjg.v13.i30.4046","article-title":"Hepatorenal syndrome","volume":"13","author":"Turban","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nephro.2008.03.005_bib22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7326\/0003-4819-126-1-199701010-00008","article-title":"Myelinolysis after correction of hyponatremia","volume":"126","author":"Laureno","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib23","first-page":"S230","article-title":"Membrane biocompatibility: effects on cardiovascular stability in patients on hemofiltration","volume":"41","author":"Davenport","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.03.005_bib24","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/hep.1840190614","article-title":"Cerebral blood flow and metabolism in fulminant liver failure","volume":"19","author":"Wendon","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/s-2007-1007251","article-title":"Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management","volume":"16","author":"Ellis","year":"1996","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.nephro.2008.03.005_bib26","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1046\/j.1523-1755.56.s.72.3.x","article-title":"Is there a role for continuous renal replacement therapies in patients with liver and renal failure?","volume":"72","author":"Davenport","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.nephro.2008.03.005_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0749-0704(05)70096-8","article-title":"Renal replacement therapies","volume":"16","author":"Meyer","year":"2000","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.nephro.2008.03.005_bib28","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00134-003-2047-x","article-title":"Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study","volume":"30","author":"Monchi","year":"2004","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/hep.510280219","article-title":"Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems","volume":"28","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib30","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199505043321803","article-title":"The transjugular intrahepatic portosystemic stent-shunt procedure for refractory ascites","volume":"332","author":"Ochs","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nephro.2008.03.005_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0168-8278(98)80151-7","article-title":"Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome","volume":"29","author":"Hadengue","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nephro.2008.03.005_bib33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S0140-6736(05)74933-3","article-title":"Improvement in renal function in hepatorenal syndrome with N-acetylcysteine","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2008.03.005_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.47.2.288","article-title":"Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study","volume":"47","author":"Brensing","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.nephro.2008.03.005_bib35","first-page":"103","article-title":"The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective randomized controlled trial and clinical experience from 19 centers","volume":"26","author":"Solanki","year":"2001","journal-title":"Artif Organs"},{"key":"10.1016\/j.nephro.2008.03.005_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/lv.2000.6355","article-title":"Improvement of hepatorenal syndrome with extracorporeal albumin dialysins MARS: results of prospective, randomized, controlled clinical trial","volume":"6","author":"Mitzner","year":"2000","journal-title":"Liver Transpl"},{"key":"10.1016\/j.nephro.2008.03.005_bib37","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/ndt\/gfm389","article-title":"Combined extended haemodialysis with single-pass albumin dialysis (SPAED)","volume":"22","author":"Rosa Diez","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.nephro.2008.03.005_bib38","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/jhep.2003.50315","article-title":"The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club","volume":"38","author":"Moore","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib39","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0168-8278(96)80297-2","article-title":"Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome","volume":"25","author":"Salo","year":"1996","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/hep.510270107","article-title":"Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion","volume":"27","author":"Guevara","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-8278(00)80158-0","article-title":"Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome","volume":"33","author":"Uriz","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib42","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1440-1746.2003.02934.x","article-title":"Beneficial effects of terlipressin in hepatorenalrenal syndrome: a prospective, randomized placebo-controlled clinical trial","volume":"18","author":"Chawla","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"issue":"suppl1","key":"10.1016\/j.nephro.2008.03.005_bib43","first-page":"694A","article-title":"A prospective randomized double blind, placebo-controlled trial for type 1 hepatorenal syndrome (HRS)","volume":"44","author":"Sanyal","year":"2006","journal-title":"Hepatology"},{"issue":"suppl1","key":"10.1016\/j.nephro.2008.03.005_bib44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0168-8278(01)80930-2","article-title":"Noradrenaline for treatment of type 1 hepatorenal syndrome (HRS) abstract","volume":"34","author":"Duvoux","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.nephro.2008.03.005_bib45","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.nephro.2008.03.005_bib46","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(96)91667-0","article-title":"Amelioration of hepatorenal syndrome with selective endothelin-A antagonist","volume":"347","author":"Soper","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.nephro.2008.03.005_bib47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.coph.2003.10.007","article-title":"Hepatorenal syndrome: pathogenesis and novel pharmacological targets","volume":"4","author":"Barada","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.nephro.2008.03.005_bib48","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"}],"container-title":["N\u00e9phrologie & Th\u00e9rapeutique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725508000618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769725508000618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.jle.com\/10.1016\/j.nephro.2008.03.005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:01:40Z","timestamp":1741183300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769725508000618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1769725508000618"],"URL":"https:\/\/doi.org\/10.1016\/j.nephro.2008.03.005","relation":{},"ISSN":["1769-7255"],"issn-type":[{"type":"print","value":"1769-7255"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}